Table 3.
Distributions of Total and Symptoms Cluster Scores on The Gynecologic Cancer Lymphedema Questionnaire (GCLQ) By Gynecologic Cancer Survivors with and without a Diagnosis of Lower Extremity Lymphedema (LLE)
|
|
|||
|---|---|---|---|
| Score (%) | 0 | 1 | |
|
|
|||
| Heaviness* (Item 14) | LLE No (n=30) | 90 | 10 |
| LLE Yes (n=28) | 32.1 | 67.9 | |
|
|
|||||
|---|---|---|---|---|---|
| Score (%) | 0 | 1 | 2 | 3 | |
|
|
|||||
| Swelling General * (Items 8, 9, 20) | LLE No (n=30) | 76.67 | 10 | 13.33 | 0 |
| LLE Yes (n=28) | 0 | 28.57 | 46.43 | 25 | |
|
|
||||
|---|---|---|---|---|
| Score (%) | 0 | 1 | 2 | |
|
|
||||
| Swelling Limb * (Items 18, 19) | LLE No (n=30) | 100 | 0 | 0 |
| LLE Yes (n=28) | 57.14 | 32.14 | 10.71 | |
|
|
||||
|---|---|---|---|---|
| Score (%) | 0 | 1 | 2 | |
|
|
||||
| Infection-related * (Items 10, 11, 13) | LLE No (n=30) | 96.67 | 3.33 | 0 |
| LLE Yes (n=28) | 46.43 | 25 | 28.57 | |
|
|
|||
|---|---|---|---|
| Score (%) | 0 | 1 | |
|
|
|||
| Aching* (Item 17) | LLE No (n=30) | 73.33 | 26.67 |
| LLE Yes (n=28) | 39.29 | 60.71 | |
|
|
||||||
|---|---|---|---|---|---|---|
| Score (%) | 0 | 1 | 2 | 3 | 4 | |
|
|
||||||
| Numbness* (Items 7, 12, 15, 16) | LLE No (n=30) | 60 | 26.67 | 13.33 | 0 | 0 |
| LLE Yes (n=28) | 7.14 | 7.14 | 28.57 | 32.14 | 25 | |
|
|
||||||||
|---|---|---|---|---|---|---|---|---|
| Score (%) | 0 | 1 | 2 | 3 | 4 | 5 | 6 | |
|
|
||||||||
| Physical Functioning* (Items 1–6) | LLE No (n=30) | 73.33 | 20 | 6.67 | 0 | 0 | 0 | 0 |
| LLE Yes (n=28) | 42.86 | 10.71 | 17.86 | 10.71 | 7.14 | 3.57 | 7.14 | |
|
|
||||
|---|---|---|---|---|
| Mean | (SE) | Median | ||
|
|
||||
| GCLQ Total Symptom Score† (All Items) | LLE No (n=30) | 1.63 | (0.33) | 1 |
| LLE Yes (n=28) | 8.89 | (0.81) | 9.5 | |
*
Physical Functioning distribution differed significantly between LLE vs. no LLE (P<0.05). All other symptom cluster scores were significantly different (P<0.001). P values are from Fisher’s exact tests for the Heaviness and Aching clusters, and from exact chi-square tests for the remaining symptom clusters.
†
GCLQ Total Symptom Scores were significantly different between LLE and no LLE, Wilcoxon rank-sum test (P<0.001).